Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Diversity of lived experience, equitable treatment, and inclusive decision-making are essential management practices.
Faculty
Applied Analytics professor Robert L. Simione II highlights recent research on the blind spots of generative AI and notes where human judgment can provide clearer vision.
Faculty
Columbia IKNS Director Christoph Meinrenken on the power of transferable passions in an increasingly interdisciplinary world.
All News
